TrialLeukemia2021

Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial.

Gerald G Wulf et al.PubMed ↗Publisher ↗

No numbers read from the abstract.